Proposed Collection; Comment Request; Evaluation of the NIAID HIV Vaccine Research Education Initiative, 34580-34581 [E9-16834]
Download as PDF
<![CDATA[
34580
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
Federal Register Citation of Previous
Announcement: 74 FR 32934 (July 9,
2009)
PREVIOUSLY ANNOUNCED TIME AND DATE OF
THE MEETING: July 14, 2009—10 a.m.
CHANGE: Withdrawal of Item 3 in the
Closed Session.
CONTACT PERSON FOR MORE INFORMATION:
Karen V. Gregory, Secretary, (202) 523–
5725.
Karen V. Gregory,
Secretary.
[FR Doc. E9–16961 Filed 7–14–09; 11:15 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Program Review of the
Division of Acquired
Immunodeficiency Syndrome Policy
Implementation Program
AGENCY:
National Institutes of Health
(NIH).
ACTION:
Notice.
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Allergy and
Infectious Diseases (NIAID), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget OMB for
review and approval.
Proposed Collection: Title: Review of
the DAIDS. Policy Implementation
Program (DPIP) .
Type of Information Collection
Request: New. Need and Use of
Information Collection: The program
review of the Division of AIDS (DAIDS)
Implementation Program DPIP), is to be
conducted over a three-year period, and
it will provide feedback to aid in the
understanding of the target population’s
knowledge, attitudes, and perceptions of
the DAIDS Policy Implementation
Program (DPIP). The target population is
classified as Extramural Researchers
(ERs), who are recipients of funding
from DAIDS to conduct and review
research. This target population is
comprised of Site Leaders of Clinical
Research Sites (CRSs) and Research
Networks and Clinical Site Monitors of
the CTUs and CRSs. The researchers are
located globally, and may be part of
Type of respondents
Data collection instrument
Extramural Researchers .................................
Extramural Researchers .................................
Estimated
frequency of
response
Survey ............................................................
Focus Groups .................................................
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Dione
Washington, Policy, Training, and
Quality Assurance Branch, National
Institute of Allergy and Infectious
Diseases, NIH, 6700B Rockledge Drive,
MSC 7620, Bethesda, MD 20892–7620
United States of America; or E-mail your
request, including your address to:
washingtondi@niaid.nih.gov.
Comments Due Date: Written
comments and recommendations for the
proposed data collection must be mailed
within 60 days of this notice.
erowe on DSK5CLS3C1PROD with NOTICES
more than one DAIDS funded research
study and/or network. The DPIP is built
upon four goals of awareness and
accessibility, understandability,
applicability, and harmonization of the
policies and procedures. The review is
to determine DPIP’s progression to
fulfillment of its program goals. The
results of the review will provide
DAIDS’ Policy, Training, and Quality
Assurance Branch (PTQAB) with
information to guide optimal
deployment of clinical research policies
and procedures intended to harmonize,
standardize and improve DAIDS
funded/sponsored research. The
program review will help derive an
understanding of whether the DPIP
program is implemented and
functioning as intended to meet its
program goals. The Estimated number of
respondent is 392. Frequency of
Response: Web-based survey; annually
(once a year). Focus Group; one time.
Affected Public: Extramural Researchers
Type of Respondents: Adult
professionals. There are no Capital Costs
to report. There are no Operating or
Maintenance Costs to report.
The annual reporting burden is
provided below:
Dated: July 9, 2009.
Judith Brooks,
Chief, Policy, Training, and Quality
Assurance Branch, NIAID, National Institutes
of Health.
[FR Doc. E9–16832 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Evaluation of the NIAID HIV
Vaccine Research Education Initiative
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Allergy and
Infectious Diseases (NIAID), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
PROPOSED COLLECTION: Title: Evaluation
of the NIAID HIV Vaccine Research
Education Initiative. Type of
Information Collection Request: New.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Estimated
average time
per response
3
1
1
2
Estimated
annual hour
burden
392
261
Need and Use of Information Collection:
Developing a vaccine that protects
against HIV infection is one of NIAID’s
highest priorities. To address the need
for volunteers in HIV vaccine clinical
trials, and enable NIAID to fulfill its
Congressional mandate to prevent
infectious diseases like HIV/AIDS,
NIAID created the NIAID HIV Vaccine
Research Education Initiative (NHVREI).
The goal of NHVREI is to increase
knowledge about and support for HIV
vaccine research among U.S.
populations most heavily affected by
HIV/AIDS—in particular, African
Americans, Hispanics/Latinos, men who
have sex with men (MSM), women and
youth, recognizing the intersection of
these groups.
The NHVREI program objectives
include (1) Increasing awareness of the
need for an HIV vaccine in communities
most affected and infected by HIV/
AIDS, (2) Improving the public’s
knowledge of and attitudes toward HIV
E:\FR\FM\16JYN1.SGM
16JYN1
34581
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
vaccine research, (3) Enhancing the
partnership between community and
HIV clinical trial researchers, and (4)
Creating support for current and future
HIV vaccine trials and fostering an
environment that supports clinical trial
volunteers.
To determine if the strategies used to
meet these objectives were successful, it
is necessary to measure the effectiveness
of initiative elements. Specifically, the
evaluation will assess (a)
implementation of NHVREI (i.e., process
evaluation) and (b) impact (i.e.,
outcomes evaluation) of NHVREI on
awareness of, knowledge about, and
support for HIV vaccine research among
NHVREI primary audiences (i.e., partner
organizations, key influencers) that
work with target populations. The
ultimate goal of evaluation planning and
implementation is to determine what
components/strategies of NHVREI are
effective and impact desired outcomes,
so that these components/strategies can
be continued, enhanced, and/or
expanded if needed.
Evaluation will be conducted through
several processes including a survey
and multiple focus groups. A survey
will be conducted with key influencers
of the NHVREI target populations to
measure their level of awareness,
knowledge about, and support for HIV
vaccine research.
Focus groups will also be conducted
with representatives of organizations
receiving grants through the NHVREI
Local Partnership Program (LPP) and
National Partnership Program (NPP), as
well as representatives from a broader
group of organizations called the
NHVREI Network. The LPP and NPP are
organizations that are funded to raise
awareness about HIV vaccine research at
either the local or national level. The
planned NHVREI network will be
composed of leadership organizations
and coalitions that are either influencers
of or provide information services to the
target populations. The purpose of
conducting focus groups with LPP, NPP,
and NHVREI Network representatives is
to obtain data on their experience
implementing NHVREI activities.
Questions asked during the group
discussions will address efforts
implementing educational activities and
developing materials, community
partnerships developed, engagement of
key influencers in program activities,
and the types of media outreach and
capacity building engaged in. Frequency
of Response: Twice. Affected Public:
Individuals. Type of Respondents: Key
influencers of target populations. The
annual reporting burden is shown in the
table below. There are no Capital Costs
to report. There are no Operating or
Maintenance Costs to report.
Average
burden
hours per
response
Estimated
total annual
burden
hours
requested
Estimated
number of
respondents
Noumber of
responses
per
respondent
78
656
1
1
1
0.33
78
216
Form name
LPP, NPP, and NHVREI Network ............
Key Influencers .........................................
Time 1
Focus Groups ...........................................
Survey ......................................................
Total Time 1 ......................................
Time 2
Focus Groups ...........................................
Survey ......................................................
734
....................
....................
294
LPP, NPP, and NHVREI Network ............
Key Influencers .........................................
78
590
1
1
1
0.33
78
195
Total Time 2 ......................................
668
....................
....................
273
Total Time 1 & Time 2 ......................
erowe on DSK5CLS3C1PROD with NOTICES
Type of respondents
1,402
....................
....................
567
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT:
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Katharine Kripke,
Assistant Director, Vaccine Research
Program, Division of AIDS, NIAID, NIH,
6700B Rockledge Dr., Bethesda, MD
20892–7628, or call non-toll-free
number 301–402–0846, or E-mail your
request, including your address to
kripkek@niaid.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: July 9, 2009.
John J. McGowan,
Deputy Director for Science Management,
NIAID, National Institutes of Health.
[FR Doc. E9–16834 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
To
request more information on the
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission to OMB, Comment
Request; An Outcome Evaluation of
the NIH Director’s Pioneer Award
(NDPA) Program
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the
Director, National Institutes of Health
(NIH), has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 74, Number 135 (Thursday, July 16, 2009)]
[Notices]
[Pages 34580-34581]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16834]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; Evaluation of the NIAID HIV
Vaccine Research Education Initiative
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Institute of Allergy
and Infectious Diseases (NIAID), the National Institutes of Health
(NIH) will publish periodic summaries of proposed projects to be
submitted to the Office of Management and Budget (OMB) for review and
approval.
PROPOSED COLLECTION: Title: Evaluation of the NIAID HIV Vaccine
Research Education Initiative. Type of Information Collection Request:
New. Need and Use of Information Collection: Developing a vaccine that
protects against HIV infection is one of NIAID's highest priorities. To
address the need for volunteers in HIV vaccine clinical trials, and
enable NIAID to fulfill its Congressional mandate to prevent infectious
diseases like HIV/AIDS, NIAID created the NIAID HIV Vaccine Research
Education Initiative (NHVREI). The goal of NHVREI is to increase
knowledge about and support for HIV vaccine research among U.S.
populations most heavily affected by HIV/AIDS--in particular, African
Americans, Hispanics/Latinos, men who have sex with men (MSM), women
and youth, recognizing the intersection of these groups.
The NHVREI program objectives include (1) Increasing awareness of
the need for an HIV vaccine in communities most affected and infected
by HIV/AIDS, (2) Improving the public's knowledge of and attitudes
toward HIV
[[Page 34581]]
vaccine research, (3) Enhancing the partnership between community and
HIV clinical trial researchers, and (4) Creating support for current
and future HIV vaccine trials and fostering an environment that
supports clinical trial volunteers.
To determine if the strategies used to meet these objectives were
successful, it is necessary to measure the effectiveness of initiative
elements. Specifically, the evaluation will assess (a) implementation
of NHVREI (i.e., process evaluation) and (b) impact (i.e., outcomes
evaluation) of NHVREI on awareness of, knowledge about, and support for
HIV vaccine research among NHVREI primary audiences (i.e., partner
organizations, key influencers) that work with target populations. The
ultimate goal of evaluation planning and implementation is to determine
what components/strategies of NHVREI are effective and impact desired
outcomes, so that these components/strategies can be continued,
enhanced, and/or expanded if needed.
Evaluation will be conducted through several processes including a
survey and multiple focus groups. A survey will be conducted with key
influencers of the NHVREI target populations to measure their level of
awareness, knowledge about, and support for HIV vaccine research.
Focus groups will also be conducted with representatives of
organizations receiving grants through the NHVREI Local Partnership
Program (LPP) and National Partnership Program (NPP), as well as
representatives from a broader group of organizations called the NHVREI
Network. The LPP and NPP are organizations that are funded to raise
awareness about HIV vaccine research at either the local or national
level. The planned NHVREI network will be composed of leadership
organizations and coalitions that are either influencers of or provide
information services to the target populations. The purpose of
conducting focus groups with LPP, NPP, and NHVREI Network
representatives is to obtain data on their experience implementing
NHVREI activities. Questions asked during the group discussions will
address efforts implementing educational activities and developing
materials, community partnerships developed, engagement of key
influencers in program activities, and the types of media outreach and
capacity building engaged in. Frequency of Response: Twice. Affected
Public: Individuals. Type of Respondents: Key influencers of target
populations. The annual reporting burden is shown in the table below.
There are no Capital Costs to report. There are no Operating or
Maintenance Costs to report.
----------------------------------------------------------------------------------------------------------------
Estimated
Noumber of Average total
Estimated responses burden annual
Type of respondents Form name number of per hours per burden
respondents respondent response hours
requested
----------------------------------------------------------------------------------------------------------------
Time 1
LPP, NPP, and NHVREI Network........ Focus Groups.......... 78 1 1 78
Key Influencers..................... Survey................ 656 1 0.33 216
---------------------------------------------------
Total Time 1....... 734 ........... ........... 294
Time 2
LPP, NPP, and NHVREI Network........ Focus Groups.......... 78 1 1 78
Key Influencers..................... Survey................ 590 1 0.33 195
---------------------------------------------------
Total Time 2....... 668 ........... ........... 273
---------------------------------------------------
Total Time 1 & Time 1,402 ........... ........... 567
2.
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Katharine Kripke, Assistant Director, Vaccine
Research Program, Division of AIDS, NIAID, NIH, 6700B Rockledge Dr.,
Bethesda, MD 20892-7628, or call non-toll-free number 301-402-0846, or
E-mail your request, including your address to kripkek@niaid.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: July 9, 2009.
John J. McGowan,
Deputy Director for Science Management, NIAID, National Institutes of
Health.
[FR Doc. E9-16834 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-P
